NewsSource: EClinCloud official website archive

EClinCloud Invites You to the 2025 Ningbo Biopharmaceutical Industry Development Conference

1 min readEClinCloud Editorial Team
Archived article cover: EClinCloud invites you to the 2025 Ningbo Biopharmaceutical Industry Development Conference

On December 5–6, the 4th China–Ningbo Biopharmaceutical Industry Development Conference will be held in Ningbo Qianwan New Area. The conference will focus on the core themes of R&D innovation and international cooperation, highlighting breakthrough pathways in frontier fields such as AI in pharmaceuticals and in vivo CAR-T, and providing an in-depth analysis of new investment and financing dynamics for innovative drugs as well as medical device innovation and practice.

EClinCloud is invited to participate deeply in this conference and will share with industry peers results in supporting clinical research with digital intelligence. We look forward to meeting and talking with you on site.

 

Presentation details

AI Pharma/Healthcare Breakout Session

Speaker: Zhang Ji | Senior Product Consultant, EClinCloud

Topic: "Current Practical Applications of LLMs in Digital Clinical Trial Systems"

Time: December 6, 14:20–14:45
大语言模型在临床研究数字化系统中的应用分享

 

Booth Information :

Booth location:

宁波生物医药活动议程  

Visit our booth to receive a gift , event gifts are limited, first come, first served

EClinCloud looks forward to seeing you there

Conference details

Conference dates: December 5–6, 2025

Conference venue: Hyatt Regency Ningbo Hangzhou Bay

Related reading

WeChat image 2026-11-11_150855_109.pngNews6 min readWorld COPD Day | Imaging Assessment in COPD Clinical ResearchNovember 13-15, 2026. November 18, 2026 marks the 25 World COPD Day, with this year's theme: Early Diagnosis and Management for a Better Life. Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by persistent airflow limitation. COPD is closely related to chronic bronchitis and emphysema [1]. We have previously covered COAs for COPD,Article imageNews3 min readAddressing Complex Challenges in Clinical Research: EClinCloud’s Full-Lifecycle AI Enablement Attracts AttentionFrom November 13–15, the 2026 Nucleic Acid Therapy and Intelligent Biomedicine Industry Innovation Conference, academically guided by the Chinese Stroke Association and hosted by the Yuanshu Brain Science Research Center, was held in Fuzhou. Dr. Qin Long, founder and CEO of EClinCloud, was invited to deliver a keynote speech titled “Practice and Application of AI in Clinical Research,” sharing insights on the development trends of AI-enabled new drug R&D and the practice of AI throughout the clinical research process, which attracted enthusiastic attention from the attending guests. 01 Current Landscape of AI-Enabled New Drug R&D: AI is demonstrating application value in multiple segments of new drug R&D, including target discoverySAPA-China 2026 CNS Forum on-site photo 1News3 min readFocusing on CNS Clinical Endpoint Assessment: EClinCloud Shares eCOA and IRC PracticesAt the CNS Forum of the SAPA-China 2026 Pharmaceutical Industry Conference, Zheng Liangyan, Medical Director at EClinCloud, shared approaches to applying eCOA and IRC, covering challenges, regulatory requirements, and practical implementation in central nervous system (CNS) disease clinical research.